Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Acute Myeloid Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01976442
What this trial is testing

Use of Saline-Washed Platelet and Red Cell Transfusions in Adult Acute Leukemia

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphoblastic, Acute
University of Rochester 100
Early research (Phase 1)Ended earlyNCT04937166
What this trial is testing

Dual-SIgnaling Protein 107 (DSP107) for Patients With Hematological Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesChronic Myelomonocytic Leukemia
Kahr Medical 25
Early research (Phase 1)Study completedNCT02835729
What this trial is testing

Indoximod in Combination With (7+3) Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
NewLink Genetics Corporation 54
Not applicableStudy completedNCT01229956
What this trial is testing

Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 32
Large-scale testing (Phase 3)Study completedNCT00952588
What this trial is testing

Study to Investigate the Efficacy, Safety and Tolerability of AZD1152 Alone and in Combination With Low Dose Cytosine Arabinoside (LDAC)in Acute Myeloid Leukaemia (AML) Patients

Who this might be right for
Acute Myeloid Leukemia
AstraZeneca 74
Large-scale testing (Phase 3)Study completedNCT02323022
What this trial is testing

Idarubicin Plus Cytarabine (IA) vs IA Plus Cladribine (IAC) as Induction Regimen to Treat Initially Diagnosed Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University 618
Large-scale testing (Phase 3)UnknownNCT00003602
What this trial is testing

Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Riverside Haematology Group 400
Testing effectiveness (Phase 2)UnknownNCT03825367
What this trial is testing

Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML

Who this might be right for
AML, Childhood
Therapeutic Advances in Childhood Leukemia Consortium 13
Testing effectiveness (Phase 2)Study completedNCT01427881
What this trial is testing

Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more
Fred Hutchinson Cancer Center 43
Testing effectiveness (Phase 2)Study completedNCT01542944
What this trial is testing

TevaGastrim for Stem Cell Mobilization Sibling Donors

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Sheba Medical Center 24
Large-scale testing (Phase 3)Study completedNCT00152139
What this trial is testing

Stem Cell Transplantation for Patients With Hematologic Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiasAcute Myelocytic LeukemiaChronic Myeloid Leukemia+4 more
St. Jude Children's Research Hospital 33
Testing effectiveness (Phase 2)Study completedNCT00028730
What this trial is testing

Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Memorial Sloan Kettering Cancer Center 25
Testing effectiveness (Phase 2)UnknownNCT00740467
What this trial is testing

Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Institut Paoli-Calmettes 50
Testing effectiveness (Phase 2)WithdrawnNCT05854966
What this trial is testing

CPI-613 Given With Metformin in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia RefractoryGranulocytic Sarcoma
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Study completedNCT00195000
What this trial is testing

Mylotarg and Ara-C in Untreated Patients Above 60 Years With AML and High-Risk MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Weill Medical College of Cornell University 43
Post-approval studies (Phase 4)Ended earlyNCT03988205
What this trial is testing

Patients Receiving Induction With Liposomal Daunorubicin and Cytarabine (CPX-351) for Acute Myeloid Leukemia

Who this might be right for
Leukemia, Myeloid, Acute
Medical College of Wisconsin 3
Not applicableStudy completedNCT00665002
What this trial is testing

Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms

Who this might be right for
Leukemia
H. Lee Moffitt Cancer Center and Research Institute 16
Early research (Phase 1)Ended earlyNCT00664677
What this trial is testing

Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia

Who this might be right for
LeukemiasAcute Myeloid Leukemia (AML)Acute Lymphocytic Leukemia (ALL)+5 more
Erimos Pharmaceuticals 16
Testing effectiveness (Phase 2)UnknownNCT00126321
What this trial is testing

Cladribine, Cytarabine and Idarubicin in Patients With Relapsed Acute Myelocytic Leukemia (AML)

Who this might be right for
Leukemia, Myelocytic, Acute
University Hospital, Bonn 50
Testing effectiveness (Phase 2)Study completedNCT00081133
What this trial is testing

Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Memorial Sloan Kettering Cancer Center
Next Page